GP may reduce the expression of FOXP3 and upregulate the ratio of Th1/Th2 in the serum, reducing the ratio of Tregs in the TME of H22 tumor-bearing mice and thus inhibiting tumor growth. Here, FOXP3 is linked to neoplasm.